Meningioma Mommas funded Dr. Garni Barkhoudarian and Dr. Daniel Kelly (John Wayne Cancer Institute at Saint John’s Health Center) with a $15,000 grant in December, 2013.

Dr. Barkhoudarian writes, “This pilot study which resulted in the identification of numerous potential biomarkers between grade 2 and grade 3 meningiomas. Though this was primarily a feasibility study, it did result in the identification of these markers which can be further analyzed in larger patient populations.  We have published our results in the Journal of Proteomics and Bioinformatics. We plan to utilize this data to submit for grant funding for a larger prospective study.”Proteomics for biomarkers of aggressive meningiomas – published article